QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

LH

QT66Labcorp Holdings Inc.
NYSE·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
255.82
-3.74-1.44%
OverviewShort InterestFilings
LHQT66Labcorp Holdings Inc.·NYSE
OverviewShort InterestFilings
255.82-1.44%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E22.69EPS (ttm)11.29
Insider Own0.53%
Shs Outstand82.00M
Perf Week-3.56%
Market Cap21.28BForward P/E13.12EPS next Y19.49Insider Trans0.05%Shs Float-Perf Month0.84%
Enterprise Value27.54BPEG0.75EPS next Q4.79Inst Own-Short Float-Perf Quarter-3.13%
Income938.62MP/S1.50EPS this Y59.55%Inst Trans-Short Ratio-Perf Half Y-0.89%
Sales14.14BP/B2.45EPS next Y8.22%ROA4.93%Short Interest-Perf YTD1.97%
Book/sh106.66P/C11.78EPS next 5Y7.95%ROE10.91%52W High293.71 -12.90%Perf Year-1.40%
Cash/sh11.96P/FCF15.38EPS past 3/5Y-ROIC7.45%52W Low241.82 5.79%Perf 3Y-
Dividend Est.2.88 (1.13%)EV/EBITDA13.35Sales past 3/5Y5.55% -0.04%Gross Margin27.79%Volatility1.36% 1.60%Perf 5Y-
Dividend TTM2.88 (1.13%)EV/Sales1.95EPS Y/Y TTM90.61%Oper. Margin11.03%ATR (14)6.08Perf 10Y-
Dividend Ex-DateMay 29, 2026Quick Ratio1.54Sales Y/Y TTM8.73%Profit Margin6.66%RSI (14)42.26Recom2.67
Dividend Gr. 3/5Y15.78% -Current Ratio1.73EPS Q/Q10.68%SMA20-2.23%Beta0.31Target Price311.33
Payout25.52%Debt/Eq0.83Sales Q/Q5.77%SMA50-2.05%Rel Volume2.43Prev Close259.56
Employees60,900LT Debt/Eq0.75EarningsJul 23SMA200-4.36%Avg Volume663.21KPrice255.82
IPO DateMar 29, 1990Option/ShortYes / YesEPS/Sales Surpr.3.41% 0.83%Net Debt/EBITDA3.03Volume1,613,504Change-1.44%
Analyst Ratings
DateActionAnalystRatingTarget
May-01-26ReiteratedRobert W. Baird$332 → $334
Apr-08-26ReiteratedEvercore ISI$280 → $300
Feb-24-26ReiteratedPiper SandlerNeutral$300
Feb-18-26ReiteratedRobert W. Baird$313 → $326
Jan-14-26ReiteratedRobert W. Baird$307 → $313
Oct-29-25ReiteratedRobert W. Baird$313 → $304
Oct-29-25ReiteratedUBSBuy$325 → $320
Oct-28-25ReiteratedLeerink Partners$342
Oct-17-25ReiteratedMizuho Securities$285 → $320
Oct-17-25ReiteratedUBSBuy$305 → $325
Latest News
Jun-18-26
Jun-18-2601:31PM
Is Labcorp Holdings Stock Underperforming the Nasdaq?Yahoo
Jun-15-26
Jun-15-2603:40PM
LH vs. CRL: Which Stock Is the Better Value Option?Yahoo
Jun-12-26
Jun-12-2601:15PM
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?Yahoo
Jun-11-26
Jun-11-2603:15PM
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?Yahoo
03:15PM
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?Yahoo
Jun-10-26
Jun-10-2601:53PM
2 S&P 500 Stocks for Long-Term Investors and 1 Facing ChallengesYahoo
01:53PM
2 S&P 500 Stocks for Long-Term Investors and 1 Facing ChallengesYahoo
Jun-08-26
Jun-08-2604:00PM
GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASHYahoo
04:00PM
GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASHYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue14,14513,95213,009
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A10,21310,2199,385
Gross Profit3,9303,7333,624
Selling, General and Administrative Excl. Other2,2212,2162,230
Research and Development000
Other Operating Expense1500308
Operating Income1,5611,5161,087
Interest Expense223224208
Unusual Expense
———
Non-Operating Income (Expense)185185-81
Net Income Before Taxes1,1531,108960
Income Taxes210230212
Consolidated Net Income942877746
Net Income From Continuing Operations943878747
Net Income942877746
EPS (Recurring)11.3710.548.89
EPS (Basic, Before Extraordinaries)11.3710.548.89
EPS (Diluted)11.2910.468.84
EBITDA2,0632,0131,811
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio22.6623.98—
Price To Sales Ratio1.481.49—
Gross Margin27.7826.7627.86
Operating Margin11.0410.878.36
Net Margin6.666.295.73
Shares Outstanding828384
Market Capitalization20,97720,823—
Operating Lease Expense
———
Insider Trading Volume
$276.12$245.83$215.54$185.25$154.96● Close Price0.00M0.77M1.55M2.32M3.10MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Kyle Kathryn WEVP, Chief Legal OfficerJun 08 '26Sale263.89762201,0843,813Jun 10 12:00 AM
Schechter Adam HPresident & CEOMay 11 '26Sale254.505,9031,502,314107,234May 13 12:00 AM
Meltzer Jonathan CEVP, OperationsMar 27 '26Sale267.05839224,0553,620Mar 30 12:00 AM
Wilkinson Peter JSVP, Chief Accounting OfficerMar 27 '26Sale267.051,633436,0931,852Mar 30 12:00 AM
Schechter Adam HPresident & CEOMar 03 '26Sale279.968,7052,437,04780,773Mar 05 12:00 AM
van der Vaart Sandra DEVP, Corporate AffairsFeb 27 '26Sale284.91548156,0002,579Mar 03 12:00 AM
Caveney Brian JEVP, Pres of ED, CMO & CSOFeb 24 '26Sale286.311,500429,45830,107Feb 26 12:00 AM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 19 '26Sale277.94666185,1081,852Feb 23 12:00 AM
Meltzer Jonathan CEVP, OperationsFeb 12 '26Sale290.428725,2672,782Feb 13 12:00 AM
Caveney Brian JEVP, Pres of ED, CMO & CSOFeb 11 '26Option Exercise0.001,480031,818Feb 13 12:00 AM
Bailey Megan D.EVP, Pres, Central Labs & IntlFeb 11 '26Option Exercise0.0080604,286Feb 13 12:00 AM
Rothman PaulDirectorFeb 11 '26Option Exercise0.001,79402,571Feb 13 12:00 AM
Wengel Kathryn EDirectorFeb 11 '26Option Exercise0.001,79404,133Feb 13 12:00 AM
Parham Richelle PDirectorFeb 11 '26Option Exercise0.001,79403,366Feb 13 12:00 AM
NEUPERT PETER MDirectorFeb 11 '26Option Exercise0.001,794013,784Feb 13 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR